Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  spleen tyrosine kinase inhibitor TAK-659
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Safety, Tolerability, and Efficacy of TAK-659 in Adults With Relapsed or Refractory Acute Myelogenous Leukemia (AML)
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: C34002, NCI-2015-00064, U1111-1163-2185, NCT02323113
A Study of TAK-659 in Adult Patients With Advanced Solid Tumor and Lymphoma Malignancies
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: C34001, NCI-2013-02382, 2013-002292-18, U1111-1165-3590, NCT02000934
MLN1117 in Combination With Docetaxel, Paclitaxel, and Other Investigational Anticancer Agents to Treat Participants With Gastric and Gastroesophageal Adenocarcinoma
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: C032-6001 (MLN1117-1003), NCI-2015-02103, 2015-001032-38, MLN1117-1003, REec-2016-2039, U1111-1166-8653, UTN, NCT02551055
Start Over